SFDA Extends Regulation Of Ephedrine-Containing Products
This article was originally published in PharmAsia News
Executive Summary
China's State FDA released a notice Feb.21 expressing intentions to further regulate the manufacture and sale of ephedrine-containing pharmaceutical products, while strictly enforcing the law to curb illegal sales